City Therapeutics ($CTY) Insider Trading & Smart Money Activity

City Therapeutics, Inc. · Biotechnology · Latest filing Oct 19, 2026

City Therapeutics, Inc. ($CTY) has 2 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($6.12M) and no insider sold, net +$6.12M.

Insider buyers (12 mo)
2
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$6.12M
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

CTY insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 2 · $6.12M 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All CTY insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Robert NelsenDirector Buy (Open-market buy) 170K sh $3.06M +1.26% SEC Read
Insider ARCH Venture Partners XII, LLC10% Owner Buy (Open-market buy) 170K sh $3.06M +1.26% SEC Read

1W / 1M / 6M = how CTY moved from the trade or filing date.

Insider trading in CTY: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Robert Nelsen Director 1 +$3.06M 13.69M Oct 19, 2026
ARCH Venture Partners XII, LLC 10% Owner 1 +$3.06M 13.69M Oct 19, 2026

Frequently asked questions

Are CTY insiders buying or selling?

Over the last 12 months 2 insiders made 2 open-market purchases worth $6.12M and 0 insiders made 0 open-market sales worth $0, a net +$6.12M.

What is the latest insider trade in CTY?

Robert Nelsen, Director filed a buy (open-market buy) of 170K sh worth $3.06M on Oct 19, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions